Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADDED: Metformin, Exercise and Diet for Knee Osteoarthritis With Overweight/Obesity
NCT07065591Phase 1Recruiting
- Sponsor
- The University of Hong Kong
- Start
- Aug 2026
- Primary completion
- Apr 2028
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of liquid metformin (Aspargo Labs) in osteoarthritis (OA) (2 arms), sponsored by The University of Hong Kong. Primary endpoint: Pain by visual analogue scale at 12 months. Started Aug 2026; status: recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT07065591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07065591.